A supportive seasonal allergic rhinitis (sar) trial showed
vs products your patients may have tried
Dymista demonstrated significantly greater improvement in total nasal symptom relief vs Astelin® (azelastine HCI) or generic Flonase® (fluticasone propionate) in patients 12 years and older.1,2
Change from baseline in the placebo-subtracted mean rTNSS for each day (maximum score 24), averaged over the 14-day study period.2
Percent difference represents the improvement in rTNSS with Dymista relative to commercially available Astelin® or generic Flonase® comparators.1,2
References: 1. Data on file. Meda Pharmaceuticals Inc., a Viatris Company. 2. Hampel FC, Ratner PH, Van Bavel J, et al. Double-blind, placebo-controlled study of azelastine and fluticasone in a single nasal spray delivery device. Ann Allergy Asthma Immunol. 2010;105(2):168-173.